Abstract
To investigate the involvement of transdifferentiation and dedifferentiation phenomena inside atherosclerotic plaques, we analyzed the differentiation status of vascular smooth muscle cells (VSMC) in vitro and in vivo. Forty normal autoptic and 20 atherosclerotic carotid endarterectomy specimens as well as 20 specimens of infrarenal and suprarenal aortae were analyzed for the expression of cytokeratins 7 and 18 and β-catenin as markers (epithelial transdifferentiation) as well as CD31 and CD34 (embryonic dedifferentiation) by conventional and double fluorescence immunohistochemistry and reverse transcription polymerase chain reaction. Looking at these markers, additional cell culture experiments with human aortic (HA)-VSMC were done under stimulation with IL-1β, IL-6, and TNF-α. Cytokeratins and β-catenin were expressed significantly higher in atherosclerotic than in normal carotids primarily localized in VSMC of the shoulder/cap region of atherosclerotic lesions. Additionally, heterogeneous cellular coexpression of CD31 and/or CD34 was observed in subregions of progressive atherosclerotic lesions by VSMC. The expression of those differentiation markers by stimulated HA-VSMC showed a time and cytokine dependency in vitro. Our findings show that (1) VSMC of progressive atheromas have the ability of differentiation, (2) that transdifferentiation and dedifferentiation phenomena are topographically diverse localized in the subregions of advanced atherosclerotic lesions, and (3) are influenced by inflammatory cytokines like IL-1β, IL-6, and TNF-α.
Similar content being viewed by others
References
Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126
Neureiter D, Heuschmann P, Stintzing S et al (2003) Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate. Atherosclerosis 168:153–162
Ross R, Glomset JA (1973) Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180:1332–1339
Dzau VJ, Braun-Dullaeus RC, Sedding DG (2002) Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8:1249–1256
Owens GK (1998) Molecular control of vascular smooth muscle cell differentiation. Acta Physiol Scand 164:623–635
Shanahan CM, Weissberg PL (1999) Smooth muscle cell phenotypes in atherosclerotic lesions. Curr Opin Lipidol 10:507–513
Shanahan CM, Weissberg PL (1998) Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol 18:333–338
Tintut Y, Alfonso Z, Saini T et al (2003) Multilineage potential of cells from the artery wall. Circulation 108:2505–2510
Owens GK (1995) Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75:487–517
Neureiter D, Herold C, Ocker M (2006) Gastrointestinal cancer—only a deregulation of stem cell differentiation? Int J Mol Med 17:483–489 Review
Neureiter D, Zopf S, Dimmler A et al (2005) Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell lines. Pancreatology 5:387–397
Brabletz T, Jung A, Spaderna S et al (2005) Opinion: migrating cancer stem cells—an integrated concept of malignant tumour progression. Nat Rev Cancer 5:744–749
Iyemere VP, Proudfoot D, Weissberg PL et al (2006) Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 260:192–210
Moiseeva EP (2001) Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res 52:372–386
Stary HC, Chandler AB, Dinsmore RE et al (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation 92:1355–1374
Hatano S (1976) Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54:541–553
Negoescu A, Labat-Moleur F, Lorimier P et al (1994) F(ab) secondary antibodies: a general method for double immunolabeling with primary antisera from the same species. Efficiency control by chemiluminescence. J Histochem Cytochem 42:433–437
Kirkeby S, Thomsen CE (2005) Quantitative immunohistochemistry of fluorescence labelled probes using low-cost software. J Immunol Methods 301:102–113
Neureiter D, Zopf S, Leu T et al (2007) Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models. Scand J Gastroenterol 42:103–116
Barber RD, Harmer DW, Coleman RA et al (2005) GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics 21:389–395
Bayliss J, Maguire JA, Bailey M et al (2008) Increased vascular endothelial growth factor mRNA in endomyocardial biopsies from allografts demonstrating severe acute rejection: a longitudinal study. Transpl Immunol 18:264–274
Hansson GK, Libby P, Schonbeck U et al (2002) Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91:281–291
Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874
Metharom P, Liu C, Wang S et al (2008) Myeloid lineage of high proliferative potential human smooth muscle outgrowth cells circulating in blood and vasculogenic smooth muscle-like cells in vivo. Atherosclerosis 198:29–38
Bader BL, Jahn L, Franke WW (1988) Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. Eur J Cell Biol 47:300–319
Bar H, Bea F, Blessing E et al (2001) Phosphorylation of cytokeratin 8 and 18 in human vascular smooth muscle cells of atherosclerotic lesions and umbilical cord vessels. Basic Res Cardiol 96:50–58
Bar H, Wende P, Watson L et al (2002) Smoothelin is an indicator of reversible phenotype modulation of smooth muscle cells in balloon-injured rat carotid arteries. Basic Res Cardiol 97:9–16
Bauriedel G, Schewe K, Windstetter U et al (1991) Differential cytokeratin expression in cultivated smooth muscle cells of primary and re-stenosed plaque tissue? Vasa Suppl 32:216–219
Denger S, Jahn L, Wende P et al (1999) Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis. Atherosclerosis 144:15–23
Glukhova MA, Shekhonin BV, Kruth H et al (1991) Expression of cytokeratin 8 in human aortic smooth muscle cells. Am J Physiol 261:72–77
Jahn L, Franke WW (1989) High frequency of cytokeratin-producing smooth muscle cells in human atherosclerotic plaques. Differentiation 40:55–62
Jahn L, Kreuzer J, von Hodenberg E et al (1993) Cytokeratins 8 and 18 in smooth muscle cells. Detection in human coronary artery, peripheral vascular, and vein graft disease and in transplantation-associated arteriosclerosis. Arterioscler Thromb 13:1631–1639
Garcia-Ramirez M, Martinez-Gonzalez J, Juan-Babot JO et al (2005) Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growth. Arterioscler Thromb Vasc Biol 25:2398–2403
Chamley-Campbell JH, Campbell GR, Ross R (1981) Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol 89:379–383
Blindt R, Vogt F, Lamby D et al (2002) Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells. J Vasc Res 39:340–352
Slomp J, Gittenberger-de Groot AC, Glukhova MA et al (1997) Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler Thromb Vasc Biol 17:1003–1009
Glukhova MA, Frid MG, Koteliansky VE (1990) Developmental changes in expression of contractile and cytoskeletal proteins in human aortic smooth muscle. J Biol Chem 265:13042–13046
Liu C, Nath KA, Katusic ZS et al (2004) Smooth muscle progenitor cells in vascular disease. Trends Cardiovasc Med 14:288–293
Johansson B, Eriksson A, Virtanen I et al (1997) Intermediate filament proteins in adult human arteries. Anat Rec 247:439–448
Campean V, Neureiter D, Nonnast-Daniel B et al (2007) CD40-CD154 expression in calcified and non-calcified coronary lesions of patients with chronic renal failure. Atherosclerosis 190:156–166
Matsumura G, Miyagawa-Tomita S, Shin'oka T et al (2003) First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108:1729–1734
Simper D, Stalboerger PG, Panetta CJ et al (2002) Smooth muscle progenitor cells in human blood. Circulation 106:1199–1204
Yeh ET, Zhang S, Wu HD et al (2003) Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108:2070–2073
Bea F, Bar H, Watson L et al (2000) Cardiac alpha-actin in smooth muscle cells: detection in umbilical cord vessels and in atherosclerotic lesions. Basic Res Cardiol 95:106–113
Amore B, Chiavegato A, Paulon T et al (1996) Atherosclerosis resistance in rats correlates with lack of expansion of an immature smooth muscle cell population. J Vasc Res 33:442–453
Trosheva M, Dikranian K, Nikolov S (1996) Expression of cytoskeletal proteins and ATPase activity in bovine femoral artery and vein intima. Histol Histopathol 11:335–342
Roberts N, Jahangiri M, Xu Q (2005) Progenitor cells in vascular disease. J Cell Mol Med 9:583–591
Majesky MW (2007) Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 27:1248–1258
Medbury HJ, Tarran SL, Guiffre AK et al (2008) Monocytes contribute to the atherosclerotic cap by transformation into fibrocytes. Int Angiol 27:114–123
Torsney E, Mandal K, Halliday A et al (2007) Characterisation of progenitor cells in human atherosclerotic vessels. Atherosclerosis 191:259–264
Bobryshev YV, Lord RS, Watanabe T et al (1998) The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions. Cardiovasc Res 40:191–205
Uglow EB, Slater S, Sala-Newby GB et al (2003) Dismantling of cadherin-mediated cell–cell contacts modulates smooth muscle cell proliferation. Circ Res 92:1314–1321
Wang X, Xiao Y, Mou Y et al (2002) A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res 90:340–347
George SJ, Beeching CA (2006) Cadherin:catenin complex: a novel regulator of vascular smooth muscle cell behaviour. Atherosclerosis 188:1–11
George SJ, Dwivedi A (2004) MMPs, cadherins, and cell proliferation. Trends Cardiovasc Med 14:100–105
Wang X, Adhikari N, Li Q et al (2004) LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 287:H2376–H2383
Heldin CH, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283–1316
Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276–1312
Ross R, Glomset J, Kariya B et al (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 71:1207–1210
Kim HR, Upadhyay S, Li G et al (1995) Platelet-derived growth factor induces apoptosis in growth-arrested murine fibroblasts. Proc Natl Acad Sci U S A 92:9500–9504
Acknowledgements
This work was supported by a Research Grant from the University of Erlangen–Nuremberg (ELAN-Fond 98.08.14.1) and in part by the IZKF Erlangen (A11). The expert technical assistance of S. Söllner, Gudrun Hülsmann-Volkert, and W. Wurm is gratefully acknowledged.
Conflicts of interest statement
We declare that we have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Sebastian Stintzing and Matthias Ocker contributed equally to this work.
Rights and permissions
About this article
Cite this article
Stintzing, S., Ocker, M., Hartner, A. et al. Differentiation patterning of vascular smooth muscle cells (VSMC) in atherosclerosis. Virchows Arch 455, 171–185 (2009). https://doi.org/10.1007/s00428-009-0800-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-009-0800-4